Related Experiment Video
Updated: Aug 30, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
An MRI study of Chlamydia pneumoniae infection in Italian multiple sclerosis patients
L M E Grimaldi1, A Pincherle, F Martinelli-Boneschi
1Department of Neurosciences, AUSL 2 Caltanissetta, Via G. Cusmano 3, 93100 Caltanissetta, Italy. luigi.grimaldi@hsr.it
Abstract:
We amplified sequences of the Chlamydia pneumoniae (CP) major-outer membrane protein in the cerebrospinal fluid (CSF) from 23 of 107 (21.5%) relapsing-remitting or secondary progressive multiple sclerosis (MS) patients and two of 77 (2.6%) patients with other neurological diseases (OND) (P = 0.00022). CP+ patients showed magnetic resonance imaging (MRI) evidence of more active disease (P = 0.02) compared to CP- MS patients and tended to have an anticipation of age at disease onset (32.3 +/- 12 versus 28.5 +/- 10 years; P = ns) causing a longer disease duration (7.5 +/- 5 versus 4.4 +/- 4 years; P = 0.016) at the time of clinical evaluation. These findings, although indirectly, suggest that CP infection of the central nervous system (CNS) might affect disease course in a subgroup of MS patients.
Insights
Chlamydia pneumoniae infection in cerebrospinal fluid was detected in 21.5% of multiple sclerosis patients, suggesting a potential role in disease activity and progression. This finding may impact the course of multiple sclerosis in affected individuals.
Area of Science:
- Neuroimmunology
- Infectious Diseases
- Neurology
Background:
- Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS).
- The role of infectious agents in MS pathogenesis remains an area of active investigation.
- Chlamydia pneumoniae (CP) is a bacterium with a potential link to neurological disorders.
Purpose of the Study:
- To investigate the presence of Chlamydia pneumoniae in the cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients.
- To explore the association between CP detection and disease activity and progression in MS.
Main Methods:
- Amplification of Chlamydia pneumoniae major-outer membrane protein sequences in CSF samples.
- Comparison of CP detection rates between MS patients and patients with other neurological diseases (OND).
- Correlation analysis between CP positivity and MRI-defined disease activity, age at onset, and disease duration in MS patients.
Main Results:
- Chlamydia pneumoniae DNA was detected in the CSF of 21.5% of MS patients versus 2.6% of OND patients (P = 0.00022).
- CP-positive MS patients exhibited significantly more active disease on MRI (P = 0.02).
- CP positivity was associated with a trend towards earlier age at disease onset and a significantly longer disease duration (P = 0.016).
Conclusions:
- The findings indirectly suggest that Chlamydia pneumoniae infection of the CNS may influence the disease course in a subset of multiple sclerosis patients.
- CP infection could be a contributing factor to disease activity and progression in multiple sclerosis.
- Further research is warranted to elucidate the direct causal relationship between CP and MS.
Related Concept Videos
Multiple Sclerosis l: Introduction
Imaging Studies for Cardiovascular System IV: CMRI
